Developing Body-Components-Based Theranostic Nanoparticles for Targeting Ovarian Cancer

Ovarian cancer mortality is the highest among gynecologic malignancies. Hence, the major challenges are early diagnosis and efficient targeted therapy. Herein, we devised model theranostic nanoparticles (NPs) for combined diagnostics and delivery of chemotherapeutics, targeted to ovarian cancer cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Edelman, Ravit, Assaraf, Yehuda G., Slavkin, Anton, Dolev, Tamar, Shahar, Tal, Livney, Yoav D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572588/
https://www.ncbi.nlm.nih.gov/pubmed/31060303
http://dx.doi.org/10.3390/pharmaceutics11050216

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572588/
https://www.ncbi.nlm.nih.gov/pubmed/31060303
http://dx.doi.org/10.3390/pharmaceutics11050216

Ejemplares similares